摘要
目的编制直肠癌低位前切除术(LAR)后症状评估量表并验证其信效度。方法通过文献检索、患者访谈、小组讨论和德尔菲专家咨询法形成初量表。2018年6月至2019年12月采用便利抽样法在中国科学院大学附属肿瘤医院抽取直肠癌LAR后患者190例进行一般资料及直肠癌LAR后症状评估量表调查,并对量表进行信效度检验。结果初量表包含5个一级指标,38个二级指标。总量表的Cronbach’sα系数为0.79,Spearman-Brown折半信度系数为0.60,重测信度为0.523(P<0.01)。12轮探索性因子分析后保留的24个条目因子载荷系数均>0.5,旋转后累积方差解释率56.78%。最终得到包含5个因子、24个条目的直肠癌LAR后症状评估量表。结论所编制的直肠癌LAR后症状评估量表具有较好的信效度,可用于临床评估。
Objective To develop the symptom assessment scale for patients with rectal cancer underwent low anterior resection(LAR)and verify its relia b ility and validity.Methods The initial scale was formed by literature search,patient interview,group discussion and Delphi expert method.By convenience sampling method,190 patients with rectal cancer underwent low anterior resection were investigated from June 2018 to December 2019,and the reliability and validity of the scale were tested.Results Five factors and 38 items were adopted in the scale.Cronbach’s a coefficient was 0.79,Spearman-Brown half re liability coefficient was 0.60,reliab ility retest was 0.523,P<0.01.Twenty-four items were adopted fina lly after 12 rounds of exploratory factor analysis,the load fa c tors were all greater than 0.5,and the cumulative variance interpretation rate after rotation was 56.78%.The symptom assessment scale for patients with rectal cancer underwent LAR was obtained,which included 5 factors and 24 items.Conclusion The symptom assessment scale for patients with rectal cancer underwent LAR has good reliability and validity,which can be used to evaluate the symptoms of those patients.
作者
刘亚婷
彭琦
谢玲女
LIU Yating;PENG Qi;XIE Lingnyu(Department of Colorectal Oncology Surgery,Cancer Hospital of the University of Chinese Academy of Sciences,Hangzhou 310022,China)
出处
《浙江医学》
CAS
2021年第7期721-725,共5页
Zhejiang Medical Journal
基金
浙江省医药卫生科技计划项目(2018ZD002)。
关键词
直肠癌
低位前切除术
症状群
量表
信效度
Rectalcancer
Low anterior resection
Symptomatic group
Scale
Reliability and validity
